The 36th Conference will focus on three areas. The first will be on how to finance, build, and operate successful state-of-the-art screening programs in practice settings around the world. The second will be on optimizing the treatment of Stage 1 lung cancer, through the IELCART Study. The third conference segment will be used to give assessments and updates on related topics.
We are delighted that the LungCentre Hirslanden, Zurich in Switzerland will be hosting this event together with the National Programme for the Early Detection of Lung Cancer®. We look forward to robust participation by our international colleagues.
Attending the Conference
Please register for the day (s) you will be attending. If you would like to stay at the conference hotel, at the discount rate, please request your preferred check-in and check-out dates For questions, please contact Maryanne Rubacky at email@example.com or through the registration link.